G62.2
Polyneuropathy due to other toxic agents
Clinical Classification Guidelines
Code First
- (T51-T65) to identify toxic agent
Medical Intelligence & Overview
Polyneuropathy due to other toxic agents, classified under ICD-10 code G62.2, refers to a nerve disorder caused by exposure to various harmful substances. This condition affects multiple peripheral nerves throughout the body, leading to a range of sensory, motor, and autonomic symptoms. Unlike primary nerve diseases, this type of polyneuropathy is directly linked to the toxic impact of external agents, which can disrupt nerve function and integrity.
Causes & Symptoms
Clinical Causes: Chronic exposure to industrial chemicals such as lead, arsenic, or thallium Prolonged use of certain medications like some chemotherapeutic agents or antibiotics Toxic effects from alcohol abuse Inhalation of toxic fumes or vapors (e.g., solvents, pesticides) Contamination from environmental toxins
Key Symptoms: Numbness, tingling, or burning sensations, often starting in the feet and legs Weakness or loss of muscle strength, especially in the lower limbs Difficulty with coordination and balance Altered sensation, such as increased sensitivity or decreased awareness of touch Autonomic symptoms like dizziness, abnormal sweating, or gastrointestinal disturbances Sharp or shooting pain in affected areas
Diagnostic & Treatment
Diagnosis Path: Diagnosis is typically made through a combination of clinical evaluation and diagnostic tests. The healthcare provider may conduct neurological examinations to assess nerve function, strength, and reflexes. Electrophysiological studies, such as nerve conduction velocities and electromyography (EMG), help determine the extent and location of nerve involvement. Blood tests may be performed to identify potential toxic agents or underlying conditions, and a detailed history of exposures can aid in establishing causality. In some cases, additional assessments like nerve biopsies or imaging studies may be necessary.
Treatment Protocols: Eliminating or reducing exposure to toxic substances to prevent further nerve damage Monitoring and supporting affected nerve functions with medications or therapies Pain management using medications such as analgesics or anticonvulsants Physical therapy to improve muscle strength, coordination, and mobility Supplements like vitamins (e.g., B vitamins) may be considered to support nerve health, depending on individual cases Addressing nutritional deficiencies or other contributing health issues
Clinical Advice & FAQs
Billing Guidance
Is G62.2 a billable ICD-10 code?
Yes, G62.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G62.2?
Clinical documentation must specify the nature of Polyneuropathy due to other toxic agents and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
